All Insights
Showing 13 - 24 of 344
Intellectual property
High Seas Treaty ratified and due to enter into force in 2026
The treaty has reached the required 60 ratifications, but the UK is still some way from ratification
Life Sciences and Healthcare
NHS' 10-year plan sets out promising UK opportunities for product manufacturers
The plan's promotion of proportionate regulation and balanced risk assessment for new products may encourage innovation
Unified Patent Court
Setting the stage: UPC Court of Appeal confirms the test for 'imminent infringement'
Zentiva's reimbursement approval found to be sufficient to meet the test and a preliminary injunction was granted against it
Life Sciences and Healthcare
UK government introduces bill to ratify landmark High Seas Treaty
Legislation creating a domestic framework to meet international obligations has first reading in Parliament, but still some way before ratification
Life Sciences and Healthcare
Digital health suppliers have at-scale opportunities delivering the UK NHS 10-year plan
Expansion of the NHS App, AI integration and wearable technology present suppliers with a clear direction on innovation
Life Sciences and Healthcare
UK private sector suppliers poised for opportunities as vanguard for NHS 10-year plan
The bold vision for a more efficient, innovative and fully digital NHS will rely heavily on the private sector
Unified Patent Court
Drop anchor! UPC uses anchor defendant to grant first Spanish preliminary injunction against a Hong Kong-based manufacturer
Hamburg LD extends UPC's long-arm jurisdiction using the manufacturer's German representative as an anchor defendant to obtain jurisdiction over its
Regulatory and compliance
How do EU product liability regulations support innovation and what to do to protect against liability risks?
Liability challenges under the revamped regime and related tech rules and safeguarding innovation while managing risk
Intellectual property
English Court of Appeal upholds validity of patent and SPC covering Astellas' blockbuster treatment for prostate cancer
Patents Court's decision affirmed to dismiss generic manufacturers' claims to revoke patent and SPC covering Xtandi®
Life Sciences and Healthcare
European Commission sets out new EU life sciences strategy
The Commission aims to position the EU as the world's most attractive place for the life sciences by 2030
Life Sciences and Healthcare
Court of Appeal upholds English High Court decision on invalidity of dapagliflozin patent and SPCs
The High Court was right to find AstraZeneca's patent and associated SPCs invalid for lack of plausibility
Life Sciences and Healthcare
EU confirms app stores and developers are subject to medical device laws
New MDCG guidelines put online stores and software developers on the medtech regulatory radar
